e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.40p
   
  • Change Today:
    -0.35p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 4,821,033
  • Market Cap: £54.93m

Deal with Barclays    Trade now with Barclays Stockbrokers

e-Therapeutics Overview

e-Therapeutics is in the pharma and biotech sector and is currently trading at 9.40p per share. In the last year e-Therapeutics's share price has ranged from 8.13p to 23.10p.
Competitors: Verici DX , Oxford Biodynamics

Key Personnel

CEO: Ali Mortazavi
Chairman: Trevor Mervyn Jones
Non-Executive Dir: Michael Anthony Bretherton

Contact Details

Address: 17 Blenheim Office Park, Long Hanborough, United Kingdom, OX29 8LN
Phone: +44 (0) 191 233 1317
Fax: +44 (0) 191 233 1303
Website: http://www.etherapeutics.co.uk/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B2823H99

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.40p
Change Today -0.35p
% Change -3.59 %
52 Week High 23.10
52 Week Low 8.13
Volume 4,821,033
Shares Issued 584.34m
Market Cap £54.93m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average
60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average
Price Trend
60.02% below the market average60.02% below the market average60.02% below the market average60.02% below the market average60.02% below the market average
5.45% above the sector average5.45% above the sector average5.45% above the sector average5.45% above the sector average5.45% above the sector average
Income Not Available
Growth
15.57% below the market average15.57% below the market average15.57% below the market average15.57% below the market average15.57% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
12:33 1,834,972 @ 9.25p
16:10 25,000 @ 9.50p
15:45 54,184 @ 9.65p
15:45 54,184 @ 9.60p
15:45 54,184 @ 9.65p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page